A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro.

M.A.I. Abou el Hassan, MJ Rabelink, W.J.F. van der Vijgh, RC Hoeben

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2140-6
JournalBritish Journal of Cancer
Issue number11
Publication statusPublished - 2003

Cite this